A detailed history of Silver Oak Securities, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Silver Oak Securities, Inc holds 10,572 shares of BMY stock, worth $494,875. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,572
Previous 6,294 67.97%
Holding current value
$494,875
Previous $291,000 63.57%
% of portfolio
0.04%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$43.31 - $48.98 $185,280 - $209,536
4,278 Added 67.97%
10,572 $476,000
Q2 2025

Jul 11, 2025

SELL
$44.12 - $59.6 $5,294 - $7,152
-120 Reduced 1.87%
6,294 $291,000
Q1 2025

Apr 21, 2025

SELL
$53.9 - $63.11 $31,423 - $36,793
-583 Reduced 8.33%
6,414 $391,000
Q4 2024

Jan 27, 2025

BUY
$51.92 - $59.94 $157,317 - $181,618
3,030 Added 76.38%
6,997 $395,000
Q3 2024

Oct 23, 2024

BUY
$39.66 - $51.75 $157,331 - $205,292
3,967 New
3,967 $205,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Silver Oak Securities, Inc Portfolio

Follow Silver Oak Securities, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Silver Oak Securities, Inc with notifications on news.